Search Results

You are looking at 1 - 1 of 1 items for :

  • "gasdermin D" x
Clear All
Majid Almansouri Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK

Search for other papers by Majid Almansouri in
Google Scholar
PubMed
Close
,
Pooja Patel Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK

Search for other papers by Pooja Patel in
Google Scholar
PubMed
Close
,
Janet Chamberlain Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK

Search for other papers by Janet Chamberlain in
Google Scholar
PubMed
Close
, and
Sheila Francis Department of Infection Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, UK
Healthy Lifespan Institute HELSI, University of Sheffield, Medical School, Sheffield, UK

Search for other papers by Sheila Francis in
Google Scholar
PubMed
Close

as control. In some experiments, cells were pre-incubated with NLRP3 inflammasome inhibitor (MCC950; 10 μM), caspase-1 inhibitor I (YVAD; 50 μM) or gasdermin D inhibitor (disulfiram; 0.5–1.0 μM) for 1 h before the addition of oxLDL. Cells were

Open access